Sponsored by HIMSS Analytics Europe
Tuesday 8 May
15:15 – 18:00
Wednesday 9 May
10:30 – 14:30
| Tuesday 8 May 2012 | 15:15 – 15:30 | Opening Keynote Dr. Varda Shalev, MD, Director of the Department of Primary Care, Maccabi Healthcare Services, Israel |
| 15:30 – 16:30 | “EMRAM Stage 7 Solutions in the US versus in Europe, Similarities and Differences” John P. Hoyt, FACHE, FHIMSS, Executive Vice President, Organizational Services HIMSS Analytics, USA Uwe Buddrus, Managing Director HIMSS Analytics Europe, Germany Dr. Peter Gocke, Director IT (CIO), Amedes, Germany |
| 16:45 – 18:00 | “Economic and Clinical Evidence for Improvements by IT: Does IT Really Improve Care and Reduce Costs?” Dr. Christian Utler, MBA, Medical Director, St. Franziskus Hospital Flensburg, Germany Guy Staals, Senior Director, Healthcare Industries Business Unit at Oracle EMEA, COCIR, The Netherlands Charles Gutteridge, National Clinical Director for Informatics at the Department of Health in England, United Kingdom |
| Wednesday 9 May 2012 | 10:30 – 11:45 | “New Generation of EMRs: Feedback on Experiences Related to Interoperability to Achieve Clinical Pathways” Prof. Christian Lovis, MD, MPH, Head of the Division of Medical Information Sciences, Switzerland Rudi van de Velde, PhD, CIO, University Hospital Brussels, Belgium Tomas Mora Morrison, M.Sc., CEO, Cambio Healthcare Systems, Sweden |
| 13:15 – 14:30 | “In-house EMR Solution Versus Vendor System” Jan de Sitter, PhD, GZA, Belgium Jan Topp Rasmussen, M.A., IT-Director Region of South Denmark, Denmark Michael Dahlweid, MD, PhD, Chief Medical Officer, Healthcare Group, CSC, COCIR, UK |
There will be a series of sessions tailored to CIO’s professional needs and interests at this year’s eHealth week. The sessions will have strong interactive character with the audience involved in discussions with the presenters. The topics are centered around EMR, encompassing discussions on in-house versus vendor-based solutions, a new generation of EMRs focusing on interoperability of systems to achieve clinical pathways and on the economic and clinical evidence for IT improvements.
Moreover, there will be a closer look on EMRAM stage 7 solutions in the US versus in Europe, on similarities and differences.
Click here to view the Programme at a Glance.